GenPath
487 Edward H Ross Dr
Elmwood Park, NJ 07407
1 800 627 1479


© 2009 GenPath is a business unit of BioReference Laboratories, Inc.

BRAF Mutational Analysis



Test Name BRAF V600E MUTATION
Also Known As BRAF Mutation
Clinical Utility and/or Limitations BRAF is a component of the cytoplasmic RAS/RAF/MAPK signal transduction pathway, which mediates transcriptional protein regulation involving cellular proliferation. Signals from the extracellular EGFR receptor may activate several intracellular pathways, including RAS, AKT, and STAT. In the RAS pathway, BRAF is downstream from RAS, and mutations of BRAF are usually mutually exclusive of K-RAS mutations. An oncogenic mutation of BRAF at V600E in exon 15 comprises 80-85% of BRAF mutations, and has been described in a variety of cancers, including melanoma (70%), thyroid (up to 30%), ovarian (up to 30%), and colorectal carcinomas (up to 15%). BRAF mutations are associated with sporadic microsatellite instability-high (MSI-H) colorectal carcinoma, but not with hereditary non-polyposis colorectal carcinoma. In colorectal carcinoma, the presence of a BRAF mutation predicts a poorer response to anti-EGFR monoclonal antibody therapeutics such as cetuximab (ERBITUX®) and panitumumab (vectibix®).
Diagnosis Under Consideration BRAF mutations are associated with sporadic microsatellite instability-high (MSI-H) colorectal carcinoma, but not with hereditary non-polyposis colorectal carcinoma.
Method PCR Amplification and Sequencing
Reference Range See Report
 
Ordering Details
Test Code 5893-3
Assay Schedule once a week
Turnaround Time 5 days
Preferred Specimen and Volume Nondecalcified Paraffin Embedded Tissue (block) containing at least 2 square mm of tumor
Alternate Specimen and Volume 2 H&E and 40 micron shaving of paraffin block containing the above amount of tumor.
 
Specimen Handling Information
Specimen Storage Room temperature: Indefinite , Refrigerated: Indefinite
Specimen Transport Ship specimen ambient except during summer months, ship with ice pack to prevent damage from the heat.
Causes For Specimen Rejection No Tumor in Block. No Patient Id and/or Surgical number on Specimen, Patient ID and/or Surgical number on specimen and Requisition doesn't match, Specimen without GenPath/BioReference requisition. Decalcified Tissue.
 
Billing Information
CPT Codes 83907 x 1:Deparaffinization, 83891 x 1:DNA extraction, 83898 x 1:PCR amplification, 83904 x 1:Mutation ID by sequencing, 83912 x 1:Interpretation and report
 
Other Information
Notes NY clients order test, 5322-3:BRAF V600E MUT.(NY ONLY).